| NPC positive | NPC negative | |
---|---|---|---|
 |  | EBV/IgA/VCA positive | EBV/IgA/VCA negative |
No. study participants | 350 | 288 | 346 |
Male/female(%male) | 233/117(67%) | 142/146(49%) | 129/217(59%) |
Age* | 48 ± 10 (16 79) | 44 ± 9 (20 77) | 47 ± 10 (18 75) |
IgA/VCA titre | 1:10-1:640 | 1:5-1:80 | < 1:5 |
IgA/EAtitre | 1:10-:160 (57.4%) | 1:5-1:20(5%) | < 1:5 |